SCHEMBL4124529

SCHEMBL4124529

CC(C(=O)Nc1ccccc1)C1CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.61
▸ MAPT P10636 5/20 0.55
▸ MEN1 O00255 4/20 0.55
▸ KMT2A Q03164 4/20 0.55
▸ LMNA P02545 2/20 0.55
▸ HTR1E P28566 2/20 0.55
▸ S1PR3 Q99500 2/20 0.55
▸ ALDH1A1 P00352 5/20 0.54
▸ RXFP1 Q9HBX9 1/20 0.54
▸ GAA P10253 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ KLK7 P49862 2/20 0.48
▸ MME P08473 1/20 0.47
▸ ACE P12821 1/20 0.47
▸ HPGD P15428 3/20 0.47
▸ HTT P42858 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ RAB9A P51151 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29582859 0.89 EPHX2 (0.50) EPHX2MAPTMEN1KMT2ALMNA
SCHEMBL17737538 0.82 IDO1 (0.58) MAPTMEN1KMT2ALMNAGAA
SCHEMBL20838723 0.82 IDO1 (0.51) EPHX2MAPTMEN1KMT2AALDH1A1
SCHEMBL20852663 0.82 IDO1 (0.51) EPHX2MAPTMEN1KMT2AALDH1A1
SCHEMBL17737122 0.82 IDO1 (0.51) EPHX2MAPTMEN1KMT2AALDH1A1
SCHEMBL17737121 0.82 IDO1 (0.51) EPHX2MAPTMEN1KMT2AALDH1A1
SCHEMBL20838737 0.82 IDO1 (0.58) MAPTMEN1KMT2ALMNAGAA
SCHEMBL17737066 0.82 IDO1 (0.58) MAPTMEN1KMT2ALMNAGAA
Hydrochloric Acid SCHEMBL7810311 0.81 KMT2A (0.58) KMT2AALDH1A1POLBRAB9A
SCHEMBL28771680 0.81 TSHR (0.47) EPHX2MAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8227480-B2 Indazole derivative having spiro ring structure in side chain UBE INDUSTRIES, LTD. (JP) 2012-07-24 — — US disclosed
US-20090170887-A1 Novel indazole derivative having spiro ring structure in side chain SANTEN PHARMACEUTICAL CO., LTD. (JP) 2009-07-02 — — US disclosed
EP-2025676-A1 NOVEL INDAZOLE DERIVATIVE HAVING SPIRO RING STRUCTURE IN SIDE CHAIN Ube Industries, Ltd. (JP) 2009-02-18 — — EP disclosed
EP-1016653-B1 Preparation of high-dye yield couplers and intermediates useful therein EASTMAN KODAK CO (US) 2004-02-25 — — EP disclosed
US-6172260-B1 Preparation of high dye-yield couplers and intermediates useful therein EASTMAN KODAK COMPANY 2001-01-09 — — US disclosed
US-6132944-A A FORMED CARBAMYLOXY GROUP OR A SULFONYLISOCYANATO GROUP LINKED A COUPLER AND A DYE; EXHIBIT A HIGHER REACTIVITY WITH OXIDIZED DEVELOPER EASTMAN KODAK COMPANY (US) 2000-10-17 — — US disclosed
EP-1016916-A1 Photographic element containing high dye-yield couplers EASTMAN KODAK COMPANY (US) 2000-07-05 — — EP disclosed
EP-1016653-A1 Preparation of high-dye yield couplers and intermediates useful therein EASTMAN KODAK COMPANY (US) 2000-07-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170887-A1 Novel indazole derivative having spiro ring structure in side chain CIT, ROCK1, ROCK2 EPHX2 1627/4885MAPT 4450/4885MEN1 3024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback